GemPharmatech Co (SHSE:688046) FFO


SHSE:688046 GemPharmatech Co Ltd SHSE:688046
95 GF Score
Price ¥23.60
GF Value ¥19.43
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is GemPharmatech Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688046
95GF Score
GemPharmatech Co Ltd SHSE:688046
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GemPharmatech Co (SHSE:688046) Overvalued in 2026?

Based on GuruFocus' analysis, GemPharmatech Co stock appears to be overvalued. The current stock price of ¥23.60 is trading 21.5% above its estimated GF Value™ of ¥19.43. GuruFocus considers GemPharmatech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688046:

  • FFO:
  • GF Value™: ¥19.43 vs. price of ¥23.60 (21.5% above fair value)
  • GF Score™: 95/100 with 8 warning signs

No single metric tells the full story. See the SHSE:688046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GemPharmatech Co Business Description

Address No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of genetically engineered mouse models and services to preclinical research and development communities. The company develops mouse models with independent intellectual property rights based on technical platforms such as gene editing, stem cells, phenotypic analysis, efficacy analysis, and sterile animals, and carries out one-stop services such as model customization, customized breeding, and functional efficacy analysis.
95GF Score

Get the complete analysis for SHSE:688046

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.60
Price
¥19.43
GF Value